Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
• Shares of Robbins & Myers, Inc. (NYSE:RBN) jumped 8.77% on strong fiscal third-quarter profits. The energy equipment supplier said strong customer demand and the recent acquisition of oilfield services has helped the company's increase its profits
• Shares of Jabil Circuit (NYSE:JBL) gained 3.18% to close at $19.45 after the company posted earnings that doubled from the previous year. The company also initiated buyback of $200 million of stock
• Apogee Enterprises (NASDAQ:APOG) reported a Q1 loss of $0.08 per share. Revenues increased 7.2% year-over-year to $153.3 million, surpassing the Zacks Consensus Estimate of $147.0 million
• Share prices of shipping service giant FedEx (NYSE:FDX) rose 2.59% after the company posted earnings that came in above analysts’ expectations. The company also projected robust earnings growth for 2012
• DENTSPLY International (NASDAQ:XRAY) said it has agreed to acquire the dental implants and medical devices unit of AstraZeneca's (NYSE:AZN) in a deal worth $1.8 billion in cash
• Internet giant Yahoo! (NASDAQ:YHOO) said it is close to resolving a dispute with Alibaba over its online e-payment segment-Alipay
• Analysts at Credit Suisse (NYSE:CS) upgraded Biogen Idec Inc. (NASDAQ:BIIB) to "Underperform" rating from “Neutral rating with a target price of $126.00
• Shares of F5 Networks (NASDAQ:FFIV) were upgraded by analysts at Barclays Capital to an "Overweight" rating from an "Equal weight" rating. Barclays Capital also raised the target price of the stock from $110 to $125
• Analysts at Deutsche Bank (NYSE:DB) upgraded Western Refining, Inc. (NYSE:WNR) to "Buy" rating from “Hold rating with a target price of $24
• Shares of SCBT Financial Co. (NASDAQ:SCBT) were upgraded by Wunderlich to “Buy rating from “Hold rating. SCBT Financial also raised the target price of the stock from $35 to $36
Read the full reports :
Analyst Report on JBL
Analyst Report on APOG
Analyst Report on FDX
Analyst Report on XRAY
Analyst Report on AZN
Analyst Report on YHOO
Snapshot Report on CS
Analyst Report on BIIB
Snapshot Report on FFIV
Snapshot Report on DB
Analyst Report on WNR